+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Infectious Disease Diagnostics Market by End User, Animal Type, Disease Category, Product Type - Global Forecast to 2030- Product Image
Veterinary Infectious Disease Diagnostics Market by End User, Animal Type, Disease Category, Product Type - Global Forecast to 2030- Product Image
Sale

Veterinary Infectious Disease Diagnostics Market by End User, Animal Type, Disease Category, Product Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715780
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Infectious Disease Diagnostics Market grew from USD 2.39 billion in 2024 to USD 2.65 billion in 2025. It is expected to continue growing at a CAGR of 10.47%, reaching USD 4.35 billion by 2030.

Navigating the Frontier of Veterinary Infectious Disease Diagnostics

The veterinary infectious disease diagnostics sphere is undergoing an unprecedented evolution driven by rising concerns over zoonotic threats, accelerating technological breakthroughs, and expanding global pet ownership trends. In this dynamic environment, stakeholders ranging from laboratory directors to veterinary clinicians are encountering both novel challenges and compelling opportunities. This report offers an authoritative exploration of the current market landscape, charting the interplay between regulatory developments, diagnostic innovation, and shifting animal health priorities. By delving into emerging testing modalities, evolving distribution models, and the influence of external factors such as trade policies, readers will gain a holistic understanding of the forces reshaping the sector. Through a rigorous examination of end user behaviors and the competitive ecosystem, this study lays the groundwork for informed decision-making. Ultimately, the introduction sets the stage for a detailed journey through the market’s transformative trends, offering clarity amid complexity and equipping industry leaders with the perspectives needed to drive strategic growth.

Transformative Trends Reshaping Diagnostic Practices

Recent years have witnessed transformative trends that are fundamentally altering how infectious diseases in animals are detected and managed. Advances in multiplex immunoassays now enable simultaneous screening for a spectrum of pathogens, reducing turnaround times while preserving diagnostic accuracy. Concurrently, the integration of digital platforms and cloud-based analytics has empowered laboratories and clinics to harness big data, automating pattern recognition and outbreak surveillance. Point-of-care testing has moved from proof of concept to mainstream practice, with compact molecular devices delivering rapid PCR and isothermal amplification results directly in clinical environments. At the same time, the push toward decentralized testing models is opening new avenues for remote and field diagnostics in livestock and wildlife populations. These shifts are not occurring in isolation; they are supported by expanding collaborations between veterinary research institutes and commercial enterprises, driving an innovation pipeline that promises greater sensitivity, specificity, and workflow efficiency. As a result, the diagnostic landscape is evolving from reactive testing toward proactive health management, setting the stage for predictive analytics and early intervention strategies.

Assessing the Impact of New Tariff Policies on the U.S. Market

The introduction of new tariffs on critical diagnostic reagents, laboratory instruments, and sequencing components in early 2025 is exerting a cumulative impact on cost structures and supply chain resilience. Import duties on molecular reagents have led to incremental price adjustments across assay portfolios, prompting many diagnostic laboratories to reevaluate procurement channels. Simultaneously, equipment manufacturers are exploring localized assembly and component sourcing to mitigate tariff-driven inflation. For veterinary hospitals and field testing units, these shifts have translated into tighter budgetary constraints and the need to balance test frequency with fiscal responsibility. Research institutes have responded by negotiating long-term supplier agreements and consolidating reagent inventories to buffer against volatility. The net effect is a palpable recalibration of purchasing strategies, with an emphasis on comprehensive service contracts and bundled consumable offerings. Although tariffs have introduced short-term headwinds, they have also catalyzed investments in domestic manufacturing capabilities, laying the foundation for enhanced supply chain security and fostering a more self-reliant diagnostic ecosystem.

Deep Dive into Market Segmentation Insights

A granular examination of market segmentation reveals nuanced drivers and adoption patterns across distinct end user groups. Diagnostic laboratories maintain a leading position by leveraging high-throughput platforms and centralized processing efficiencies, while research institutes are propelling next-generation assay development through collaborative grant-funded projects. Veterinary hospitals are integrating rapid in-house testing into clinical workflows to deliver immediate treatment guidance. Animal type also informs demand dynamics, with companion animals generating robust interest in point-of-care immunoassays and molecular tests due to heightened pet owner expectations. Equine practices are increasingly adopting molecular assays to detect respiratory pathogens, whereas livestock and poultry operations deploy culture-based screenings and real-time PCR assays to manage herd health. Wildlife surveillance programs rely on portable molecular devices to monitor emerging zoonoses in remote habitats. When disease categories are considered, bacterial assays remain foundational, especially for mastitis and respiratory infections, yet viral diagnostics enjoy the fastest uptake driven by concerns over viral zoonosis and vaccination efficacy. Fungal and parasitic testing segments are gaining momentum, especially in regions with endemic mycotic diseases or vector-borne parasite exposure. Product type segmentation underscores the steady demand for clinical chemistry and hematology analyzers as baseline assessments. Culture-based methods continue to serve as the gold standard for confirmatory diagnostics despite longer incubation periods. Immunoassays offer rapid results for acute screening, while molecular diagnostics represent the vanguard of precision, with polymerase chain reaction and quantitative PCR assays dominating current workflows. The molecular diagnostics segment is further elevated by isothermal amplification techniques for field diagnostics and by next-generation sequencing technologies-ranging from high-throughput Illumina platforms to portable Oxford Nanopore and classical Sanger sequencing-that enable comprehensive pathogen characterization and surveillance.

Regional Nuances Driving Diagnostic Adoption

Regional dynamics play a pivotal role in shaping investment priorities, regulatory approaches, and end user preferences. In the Americas, North America leads in test volume and technology adoption, fueled by a mature diagnostic infrastructure and strong R&D collaboration networks. Latin American initiatives are focused on expanding access to affordable field diagnostics to manage endemic diseases in livestock and wildlife. The Europe, Middle East and Africa region exhibits diverse market maturity levels; Western Europe is characterized by stringent regulatory frameworks and high adoption of advanced molecular platforms, whereas emerging economies in the Middle East and Africa are prioritizing capacity building and diagnostic deployment in large-scale vaccination and surveillance campaigns. In Asia-Pacific, rapid economic growth and rising per capita spending on pet health are driving demand for premium immunoassays and next-generation sequencing applications. Markets such as China, India and Australia are investing heavily in domestic manufacturing of reagents and instruments to support localized supply chains. Cross-regional collaborations, whether through research partnerships or harmonized regulatory pathways, are further accelerating technology diffusion and elevating overall diagnostic standards on a global scale.

Competitive Landscape and Leading Innovators

The competitive landscape is defined by a blend of established diagnostic giants and agile specialized firms that are pushing the boundaries of assay sensitivity and automation. Leading corporations have strengthened their market positions through strategic acquisitions that integrate molecular and immunoassay portfolios, enabling seamless end-to-end workflow solutions. Innovative start-ups are carving out niches by developing portable point-of-care platforms and AI-driven diagnostic software, often entering partnerships with academic research centers to accelerate validation and clinical adoption. Collaborative alliances between veterinary hospitals and reagent suppliers have given rise to integrated service models, under which testing equipment is bundled with reagent supply and technical support, reducing entry barriers for mid-sized practices. At the same time, emerging players are differentiating through open-source sequencing kits and cloud-based data interpretation tools, democratizing access to advanced diagnostics. Across the spectrum, companies are prioritizing sustainability by reducing plastic consumables, optimizing reagent volumes, and designing energy-efficient instruments that align with evolving environmental regulations and corporate responsibility goals.

Strategic Recommendations for Industry Leadership

Industry leaders must adopt a forward-looking posture to capitalize on evolving market dynamics and safeguard against emerging risks. Organizations should prioritize investment in modular molecular platforms that support both PCR and isothermal amplification assays, enabling rapid reconfiguration of testing panels in response to new pathogen threats. Building strategic partnerships with reagent manufacturers and instrument OEMs can secure preferential pricing and streamline access to next-generation sequencing workflows. To address tariff-induced supply chain pressures, companies are advised to diversify sourcing by establishing regional manufacturing alliances and exploring contract development and manufacturing organizations for critical reagents. Expanding service offerings to include remote diagnostics and telehealth integrations will meet growing demand for decentralized testing in livestock and wildlife applications. Moreover, leveraging advanced data analytics and AI-driven decision support can transform raw diagnostic outputs into actionable insights for veterinarians and epidemiologists. Finally, fostering cross-sector collaborations-spanning research institutes, government agencies, and private enterprises-will accelerate innovation and drive comprehensive disease surveillance strategies.

Robust Research Methodology Underpinning Our Analysis

This analysis is underpinned by a rigorous multi-phase research methodology designed to ensure accuracy, relevance, and depth. The process began with an exhaustive review of scientific literature, regulatory filings, and market intelligence databases to map current practices and emerging technologies. Primary research included in-depth interviews with laboratory directors, veterinary clinicians, animal health researchers, and supply chain experts to capture firsthand perspectives on diagnostic adoption and operational challenges. Secondary research complemented these insights with quantitative data from industry reports, peer-reviewed journals, and government publications. All collected information underwent a triangulation process to validate key findings and reconcile discrepancies between sources. The final report framework was peer-reviewed by an advisory panel of industry veterans to ensure that strategic implications reflect real-world decision-making imperatives. This robust approach underlies the credibility and actionable nature of the analyses presented herein.

Synthesis and Key Takeaways

As the veterinary infectious disease diagnostics sector continues to expand and innovate, stakeholders will need to navigate a complex array of technological, regulatory, and economic forces. This summary has highlighted the transformative impact of molecular and immunoassay advancements, the strategic ripple effects of new tariff structures, and the granular distinctions across end users, animal types, disease categories, and product modalities. Regional insights underscore the heterogeneous adoption patterns and collaborative initiatives that characterize the global market. Competitive analysis reveals a vibrant ecosystem of established players and emerging disruptors, each contributing to a stronger, more resilient sector. By synthesizing these insights, this report equips decision-makers with the strategic context required to anticipate shifts, optimize portfolios, and drive sustainable growth in the years ahead.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End User
    • Diagnostic Laboratories
    • Research Institutes
    • Veterinary Hospitals
  • Animal Type
    • Companion Animals
    • Equine
    • Livestock
    • Poultry
    • Wildlife
  • Disease Category
    • Bacterial
    • Fungal
    • Parasitic
    • Viral
  • Product Type
    • Clinical Chemistry And Hematology
    • Culture Based
    • Immunoassays
    • Molecular Diagnostics
      • Isothermal Amplification
      • Next Generation Sequencing
        • Illumina Sequencing
        • Oxford Nanopore
        • Sanger Sequencing
      • Pcr
      • Qpcr
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Heska Corporation
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • bioMérieux SA
  • Becton Dickinson and Company
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck & Co., Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Infectious Disease Diagnostics Market, by End User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Research Institutes
8.4. Veterinary Hospitals
9. Veterinary Infectious Disease Diagnostics Market, by Animal Type
9.1. Introduction
9.2. Companion Animals
9.3. Equine
9.4. Livestock
9.5. Poultry
9.6. Wildlife
10. Veterinary Infectious Disease Diagnostics Market, by Disease Category
10.1. Introduction
10.2. Bacterial
10.3. Fungal
10.4. Parasitic
10.5. Viral
11. Veterinary Infectious Disease Diagnostics Market, by Product Type
11.1. Introduction
11.2. Clinical Chemistry And Hematology
11.3. Culture Based
11.4. Immunoassays
11.5. Molecular Diagnostics
11.5.1. Isothermal Amplification
11.5.2. Next Generation Sequencing
11.5.2.1. Illumina Sequencing
11.5.2.2. Oxford Nanopore
11.5.2.3. Sanger Sequencing
11.5.3. Pcr
11.5.4. Qpcr
12. Americas Veterinary Infectious Disease Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Veterinary Infectious Disease Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Veterinary Infectious Disease Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. IDEXX Laboratories, Inc.
15.3.2. Zoetis Inc.
15.3.3. Heska Corporation
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. QIAGEN N.V.
15.3.6. bioMérieux SA
15.3.7. Becton Dickinson and Company
15.3.8. Neogen Corporation
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. Merck & Co., Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY WILDLIFE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY AND HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OXFORD NANOPORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 52. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 54. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 55. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 58. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 60. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 86. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 88. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 89. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 91. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 92. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 95. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 97. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 100. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 101. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 103. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 104. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 106. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 107. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 109. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 110. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 112. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 113. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 115. SPAIN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. UNITED ARAB EMIRATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 134. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 139. DENMARK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 146. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 149. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. QATAR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 152. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 155. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 157. FINLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 160. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 161. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 163. SWEDEN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 170. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 172. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 173. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 175. EGYPT VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 176. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 179. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 181. TURKEY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 188. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 191. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 193. NORWAY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 194. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 196. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 197. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 199. POLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 202. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 203. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 205. SWITZERLAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 213. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 215. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 216. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 218. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 219. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 221. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 222. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 224. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 225. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 227. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 228. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 230. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 249. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 251. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 252. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 254. THAILAND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM VETERINARY INFECTIOUS DISEASE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Veterinary Infectious Disease Diagnostics market report include:
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Heska Corporation
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • bioMérieux SA
  • Becton Dickinson and Company
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck & Co., Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.65 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.35 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Veterinary Infectious Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Veterinary Infectious Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Veterinary Infectious Disease Diagnostics Market Report by Technology, Animal Type, Infection Type, End User, and Region 2024-2032 - Product Image

Veterinary Infectious Disease Diagnostics Market Report by Technology, Animal Type, Infection Type, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Veterinary Infectious Disease Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Veterinary Infectious Disease Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From
Veterinary Infectious Disease Diagnostics Market Report 2025 - Product Image

Veterinary Infectious Disease Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Veterinary Molecular Diagnostic Market by Animal Type, Technology, End User, Disease Type, Product - Global Forecast to 2030 - Product Image

Veterinary Molecular Diagnostic Market by Animal Type, Technology, End User, Disease Type, Product - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From

About the Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the diagnosis and treatment of infectious diseases in animals. Veterinary infectious disease diagnostics involve the use of laboratory tests to detect and identify the presence of infectious agents in animals. These tests can be used to diagnose a wide range of diseases, including bacterial, viral, fungal, and parasitic infections. Veterinary infectious disease diagnostics also involve the use of imaging techniques, such as X-rays and ultrasounds, to detect and monitor the progression of infectious diseases. The Veterinary Infectious Disease Diagnostics market is driven by the increasing prevalence of animal diseases, the growing demand for pet insurance, and the rising awareness of animal health and welfare. Additionally, the development of new diagnostic technologies and the increasing availability of veterinary diagnostic services are expected to drive the growth of the Veterinary Infectious Disease Diagnostics market. Some companies in the Veterinary Infectious Disease Diagnostics market include IDEXX Laboratories, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Abaxis, Inc., and Zoetis, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.